Dr. Reddy trialing Topical Itraconazole 5% (DFD-04)

Written by on July 15, 2016 in clinical trials, New Rosacea Treatments with 0 Comments

Dr. Reddy has listed a clinical trial to continue to investigate Topical Itraconazole 5% as a treatment for the papules and pustules of rosacea. So we can add DFD-04 to the list of new drugs in development for rosacea.

From Dr. Reddy’s 2015 Investor Day Presentation.

We target underserved segments within large disease areas both in Dermatology and Neurology.

Mid-stage dermatology assets

Rosacea: 16M sufferers, 0.8-1M Underserved Segment.

DFD-04: Phase 1, novel repurposed topical API for treatment of rosacea

Clinical Trial NCT02828241

A Study to Assess the Efficacy, Safety and Tolerability of DFD-04

Sponsor: Dr. Reddy’s Laboratories Limited
Study start date: June 2016
Locations: Germany

From a related listed on clinicaltrials.eu, we can see that DFD-04 is topical Itraconazole 5%.

EudraCT Number: 2015-005486-23


A Placebo controlled study to test DFD-04 Ointment 5% in patients with rosacea over 12-weeks

A Multi-center, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study to Assess the Efficacy, Safety and Tolerability of DFD-04 (itraconazole) Ointment, 5% in Patients with Inflammatory Lesions of Rosacea Over 12-weeks

Related Articles

About the Author

About the Author: David Pascoe started the Rosacea Support Group in October 1998. .

Follow Rosacea Support

Subscribe via RSS Feed

Leave your comment here


Subscribe to Rosacea News

Enter your email address to receive the latest news about rosacea in your inbox.